Latest news
FMR LLC reveals 6.2% Mirum Pharmaceuticals (MIRM) ownership in Schedule 13G - Stock TitanStock Titan · Thu, 06 Aug 2026 14:34:54 GMTMirum Pharmaceuticals Q2 2026 Earnings Call Transcript - MarketBeatMarketBeat · Thu, 06 Aug 2026 05:00:36 GMTMirum Pharmaceuticals Q2 Loss Widens, Revenue Rises; Shares Fall - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 21:58:59 GMTMirum Pharmaceuticals, Inc. (MIRM) Reports Q2 Loss, Beats Revenue Estimates - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 21:25:05 GMTMirum Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Wed, 05 Aug 2026 21:01:53 GMTMirum Pharmaceuticals (MIRM) SVP sells 1,840 shares under 10b5-1 plan - Stock TitanStock Titan · Wed, 05 Aug 2026 20:27:23 GMTMirum Pharmaceuticals (Nasdaq: MIRM) takes $857M H1 2026 net loss - Stock TitanStock Titan · Wed, 05 Aug 2026 20:08:13 GMTMirum Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 20:01:00 GMT